Herceptin® (trastuzumab) delivery methods: an interview with Dr Gustavo Ismael
Approximately 20% of all breast cancer patients have overexpression of HER2 (human epidermal growth factor receptor 2), resulting in a more aggressive phenotype, and a poor prognosis.